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Background-—Increased renal resistive index (RRI) has been associated with target organ damage as well as renal and
cardiovascular outcomes. Matrix Gla (c-carboxyglutamate) protein (MGP) is a strong inhibitor of soft tissue calciﬁcation. Its inactive
form (dephospho-uncarboxylated MGP [dp-ucMGP]) has been associated with vascular stiffness, cardiovascular outcomes, and
mortality. In this study, we hypothesized that high levels of dp-ucMGP were associated with increased RRI.
Methods and Results-—We recruited participants via a multicenter family-based cross-sectional study in Switzerland. Levels of dp-
ucMGP were measured in plasma by sandwich ELISA. RRI was measured by Doppler ultrasound in 3 segmental arteries in both kidneys.
We used mixed regression models to assess the relationship between dp-ucMGP and RRI. We adjusted for common determinants of RRI
as well as renal function and cardiovascular risk factors. We included 1006 participants in our analyses: 526 women and 480 men. Mean
values were 0.440.20 nmol/L for dp-ucMGP and 645% for RRI. After multivariable adjustment, dp-ucMGP was positively associated
with RRI (P=0.001). In subgroup analysis by age tertiles, this association was not signiﬁcant in the youngest age group (<38 years;
P=0.62), whereas it was signiﬁcant in older age groups (38–55 and >55 years; P=0.016 and P<0.001, respectively).
Conclusions-—Levels of dp-ucMGP are positively and independently associated with RRI after adjustment for common
determinants of RRI, cardiovascular risk factors, and renal function. The stronger association among older adults is probably due, in
part, to age-related arterial stiffness. RRI thus seems to reﬂect the global atherosclerotic burden in a general adult population. ( J
Am Heart Assoc. 2019;8:e013558. DOI: 10.1161/JAHA.119.013558.)
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R enal resistive index (RRI) is the difference between themaximum systolic velocity and the end-diastolic velocity
divided by the maximum systolic velocity. Velocities are
measured by renal Doppler ultrasound of interlobar arteries.1
Despite use for several decades, the clinical interpretation of
RRI remains unclear. In a population-based study that
included people with mainly preserved renal function and
normal renal ultrasound, factors associated with RRI were sex,
age, blood pressure (BP), heart rate (HR), and body mass
index (BMI).2 In patients with kidney disease, RRI correlated
with the renal pathological process itself.3 In contrast, in
kidney transplant recipients, RRI depended mainly on sys-
temic vascular properties.4 Moreover, an elevated RRI could
serve as a marker of target organ damage, as RRI is
associated with adverse renal and cardiovascular outcomes.5
This latter ﬁnding supports the hypothesis that intrinsic renal
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resistance is only a minor determinant of RRI and that RRI
depends mainly on extrarenal systemic hemodynamic param-
eters such as pulse pressure (PP) and vascular compliance.6
High PP and/or low vascular compliance would thus be the
main predictors of elevated RRI. This theoretical view is
supported by some experimental evidence, but information
from clinical studies in humans remains sparse.7–9
Matrix Gla (c-carboxyglutamate) protein (MGP) is a strong
inhibitor of soft tissue calciﬁcation.10,11 MGP knockout mice
develop massive vascular calciﬁcation in their ﬁrst weeks of life
and die within 2 months of vessel rupture.12 To acquire its full
calciﬁcation inhibitory activity, MGP needs to undergo 2
posttranslational modiﬁcations. Consequently, 4 different MGP
conformations can be found: (1) unmodiﬁed and inactive
dephospho-uncarboxylatedMGP (dp-ucMGP), (2) phosphorylated
only, (3) carboxylated only, and (4) fully modiﬁed and active
phosphorylated and carboxylated MGP.13,14 Carboxylation of
MGP is a vitamin K–dependent process because vitamin K
hydroquinone is an active cofactor of the carboxylation of
glutamate residues into Gla.15 Therefore, dp-ucMGP is an inverse
marker of vitamin K status, in which high circulating levels reﬂect
poor vitamin K stores.16 Active MGP adsorbs extracellular
hydroxyapatite, inhibiting crystal growth.15 It also inhibits
vascular smoothmuscle cell apoptosis by binding to BMP2 (bone
morphogenetic protein 2), a proapoptotic agonist.17 Active MGP
protects the microcirculation and organ function.18 Levels of dp-
ucMGP have been associated with vascular stiffness measured
by carotid–femoral pulse wave velocity (PWV) in 2 population-
based independent studies involving >1000 participants.19,20
To clarify the pathophysiological and clinical meaning of
RRI in the general adult population, we assessed whether RRI
was associated with dp-ucMGP as a marker of systemic
vascular calciﬁcation.
Methods
The data that support the ﬁndings of this study are available
from the corresponding author upon reasonable request.
Participant Selection
SKIPOGH (Swiss Kidney Project on Genes in Hypertension) is
a family-based cross-sectional study exploring the role of
genes and kidney hemodynamics in BP regulation and kidney
function in the general population.21 From December 2009 to
March 2013, adult participants were recruited in 2 regions
(Bern and Geneva) and 1 city (Lausanne) in Switzerland. The
population-sampling method has been described in detail
previously.21 Inclusion criteria were (1) a minimum of
18 years of age, (2) European ancestry, (3) ﬁrst-degree family
members who were willing to participate, and (4) written
informed consent. Pregnant or breastfeeding women were not
included. The institutional ethics committees of the partici-
pating university hospitals approved the SKIPOGH study.
Study Visit
Participants were seen in the morning after an overnight fast.
BP was measured 5 times after a resting period of ≥10 min-
utes in the sitting position with a nonmercury manual
auscultatory sphygmomanometer (A&D UM-101), according
to the guidelines of the European Society of Hypertension.22
For the analyses, we used the mean of the last 4 BP and HR
measurements.
Laboratory Data
Blood venous samples were drawn after an overnight fast.
Blood glucose, electrolytes, kidney and liver function tests,
serum cholesterol, and triglycerides were analyzed by
standard clinical laboratory methods. Levels of dp-ucMGP
were assessed in EDTA plasma using the InaKtif iSYS Kit
(IDS), which is a precommercial dual-antibody test based on
the sandwich ELISA, developed by VitaK (Maastricht Univer-
sity, The Netherlands). Intra-assay variation coefﬁcients are
3.1% for the upper limit of the normal range and 5.4% for the
lower limit of the normal range. Interassay variation coef-
ﬁcients are 6.9% for the upper limit of the normal range and
13.6% for the lower limit of the normal range (Unpublished
data from Cees Vermeer, PhD, R&D Group VitaK, Maastricht
University, Maastricht, The Netherlands).
Clinical Perspective
What Is New?
• We assessed the relationship between renal resistive index
and the inactive form of matrix Gla (c-carboxyglutamate)
protein (dephospho-uncarboxylated matrix Gla protein) as a
marker of systemic vascular calciﬁcation in a general adult
population.
• Renal resistive index was positively associated with levels of
dephospho-uncarboxylated matrix Gla protein, independent
of common determinants of renal resistive index, cardio-
vascular risk factors, and renal function.
What Are the Clinical Implications?
• These ﬁndings suggest that renal resistive index reﬂects the
global atherosclerotic burden in healthy participants and
could identify patients who might beneﬁt from vitamin K
supplementation.
• Whether this supplementation would result in a meaningful
improvement in clinical outcome remains to be demon-
strated in randomized controlled trials.
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Renal Doppler Ultrasound
In each study center, the same experienced operator
performed renal gray-scale and color duplex ultrasounds,
according to a standardized procedure, as described previ-
ously.2 Brieﬂy, RRI was measured in 3 segmental arteries
(superior, middle, and inferior) of each kidney. The values
were then averaged to obtain a mean value for each
participant. The reproducibility of RRI measurements was
assessed in a subgroup of 20 unrelated participants with
inter- and intraobserver Lin correlation coefﬁcients of 0.75
and 0.89, respectively, for the right kidney and 0.69 and 0.72,
respectively, for the left kidney. Values were multiplied by 100
to express the RRI results as percentages.
Pulse Wave Velocity
Arterial waveforms were assessed during an 8-second period
in the supine position after 15 minutes of rest at the carotid
and femoral arteries by applanation tonometry, using a high-
ﬁdelity SPC-301 micromanometer (Millar Instruments), inter-
faced with a laptop computer running the SphygmoCor
software v8.0 or v8.2 (AtCor Medical). In each study center,
the same experienced operator obtained the arterial wave-
forms and recorded carotid–femoral PWV, as described
previously.19
Deﬁnitions
Diabetes mellitus was deﬁned as present when reported or
treated or when fasting blood glucose level was ≥7 mmol/L.
Hypertension was considered present when treated or when
mean ofﬁce BP was ≥140/90 mm Hg, according to European
guidelines.22 PP was deﬁned as systolic BP (SBP) minus
diastolic BP (DBP). The Chronic Kidney Disease Epidemiology
Collaboration (CKD-EPI) formula was used to estimate
glomerular ﬁltration rate (eGFR), and an eGFR <60 mL/min
per 1.73 m2 deﬁned chronic kidney disease. Kidney ultra-
sound was considered abnormal in any case of unilateral
kidney, cysts, atrophy, stone, hydronephrosis, partial nephrec-
tomy, suspected renal artery stenosis, horseshoe kidney, or
any other kidney malformation.
Statistical Analysis
Continuous variables are expressed as meanSD and cate-
gorical variables as number and relative frequencies. Normal-
ity of distribution was assessed graphically. Outliers were
deﬁned as participants with RRI or dp-ucMGP values >99th or
<1st percentile. RRI was divided in tertiles to assess
associations with baseline characteristics. Variables were
compared using v2 tests and ANOVA or Kruskal–Wallis
tests (depending on normality and homoscedasticity) for
categorical and continuous variables, respectively, and Cuzick
trend tests.
In univariable linear regression analysis, we explored the
relationship of RRI with the following variables: dp-ucMGP,
age, height, BMI, HR, eGFR, LDL (low-density lipoprotein), HDL
(high-density lipoprotein), glucose, SBP, DBP, sex, smoking
status, diabetes mellitus, antihypertensive treatment, dyslipi-
demia treatment, and cardiovascular disease (CVD).
To characterize the relationship between RRI and dp-
ucMGP, multiple linear regressions were conducted using a
backward stepwise approach, and in the ﬁnal model, only
variables with P<0.05 were kept. In a ﬁrst step, variables
associated with RRI were identiﬁed, omitting dp-ucMGP.
Similarly, variables associated with dp-ucMGP were identiﬁed,
omitting RRI. Then we set a model including as covariates all
variables yielded from the previous 2 steps, with dp-ucMGP as
the factor of interest and RRI as the outcome. Because age
has been demonstrated to have a quadratic relationship with
RRI, age and the square of age were included in multivariable
models.2 All models were treated as mixed models with the
participant’s family as the clustering variable and intercept as
a random effect. All models were also adjusted for study
center as a ﬁxed effect. Results are presented as b
coefﬁcients (corresponding to a 1-U increment for continuous
variables or difference between 2 categories in categorical
variables) and associated 95% CIs and P values. An alternative
analysis used mixed multivariable logistic regression with dp-
ucMGP >70% as the dependent variable. The other charac-
teristics of this model were identical to our main linear model.
In the ﬁnal multivariable model, we looked for a modiﬁ-
cation effect or interaction between dp-ucMGP and the
following variables: abnormal kidney on ultrasound, sex,
chronic kidney disease, antihypertensive treatment, hyper-
tension, and age. Because age has a quadratic relationship
with RRI, this variable was divided in tertiles to allow
interaction testing. The likelihood ratio test (LRT) was used
to compare models with and without interaction terms.
Linearity was assessed graphically by scatterplots and by
LRT comparing models including the variable as continuous
versus categorical.
As secondary analyses, we explored the relationship
among RRI, PP, and PWV. In a ﬁrst multivariable regression,
only PP and PWV were considered as independent variables.
In a second multivariable regression model, factors associated
with RRI in our main model (except dp-ucMGP) were
introduced as independent variables.
Data were considered to be missing completely at random;
therefore, patients with any missing variables were excluded
from the multivariable analyses. Statistical analyses were
conducted using STATA v15 (StataCorp). P<0.05 was consid-
ered signiﬁcant. For interactions, the P value was set at <0.1
for interaction terms and/or LRT.
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Results
The complete SKIPOGH cohort included 1128 participants.
For these analyses, we excluded 4 participants on anti–
vitamin K medication and 80 with missing data on RRI and/or
dp-ucMGP. Among the 1044 remaining participants, 38 were
outliers, leaving 1006 for the main analyses (Figure S1).
Mean values of RRI and dp-ucMGP were 645% and
0.440.20 nmol/L, respectively. In total, 128 of 1006
patients (12.7%) had RRI values >70%. Overall, 52.3% were
women, and mean age was 46.717.2 years. Participant
characteristics are described according to RRI tertiles in
Table 1. Low, medium, and high RRI tertile values were
<61%, 61% to 65% and >65%, respectively. Women had
higher RRIs than men (P<0.001). Across increasing tertiles
of RRI, more participants had diabetes mellitus, hyperten-
sion, chronic kidney disease, history of cardiovascular
disease, BP- and lipid-lowering drugs, or abnormality on
kidney ultrasound (all P<0.05). There was a trend only
toward fewer smokers in higher RRI tertiles. Dp-ucMGP,
PWV, age, BMI, glucose, and SBP increased within RRI
tertiles (all P<0.001), whereas height, eGFR, and DBP
decreased with higher categories of RRI (all P<0.05). There
was a trend only toward higher LDL and fewer smokers
across increasing tertiles (for trend, P=0.04 and P=0.03,
respectively).
Table 1. Patients Characteristics According to Tertiles of RRI (n=1006, Without Outliers)
Characteristics n Overall
Low RRI (<61%)
n=347
Medium RRI (61–65%)
n=333
High RRI (>65%)
n=326 P Value
RRI mean value % 1006 645 582 631 703 <0.001
Categorical variables and comorbidities, n (%)
Female 1006 526 (52.3) 151 (43.5) 177 (53.2) 198 (60.7) <0.001
Smoker 1006 243 (24.2) 94 (27.1) 84 (25.2) 65 (19.9) 0.08*
Diabetes mellitus 996 34 (3.4) 3 (0.9) 5 (1.5) 26 (8.1) <0.001
Hypertension 1002 222 (22.2) 42 (12.2) 50 (15) 130 (40.1) <0.001
BP-lowering drugs 1003 151 (15.1) 23 (6.7) 34 (10.2) 94 (28.9) <0.001
Lipid-lowering drugs 1003 39 (3.9) 4 (1.2) 17 (5.1) 18 (5.5) 0.01
CVD 994 99 (10.0) 16 (4.7) 34 (10.2) 49 (15.4) <0.001
Abnormal kidney 999 189 (18.9) 40 (11.7) 67 (20.2) 82 (25.2) <0.001
CKD 1006 23 (2.3) 3 (0.9) 1 (0.3) 19 (5.8) <0.001
Clinical characteristics, meanSD
Age, y 1006 46.717.2 38.613.0 44.215.2 58.117.1 <0.001
Height, cm 1006 1719 1739 1719 1679 <0.001
BMI, kg/m2 1006 25.04.5 24.03.8 25.25.0 25.84.5 <0.001
SBP, mm Hg 1005 11716 11212 11414 12520 <0.001
DBP, mm Hg 1005 75.59.7 76.69.6 74.89.2 75.110.3 0.04
PP, mm Hg 1005 41.511.8 35.87.5 39.58.5 49.713.7 <0.001
HR, beats/min 999 66.710.7 67.611.0 66.110.7 66.210.2 0.1
Laboratory characteristics, meanSD
dp-ucMGP, nmol/L 1006 0.440.20 0.390.17 0.430.20 0.520.22 <0.001
GFR, mL/min/1.73 m2 1000 97.217.3 10415 99.115.2 88.118.0 <0.001
LDL, mmol/L 995 3.110.92 3.050.92 3.110.90 3.190.94 0.12†
HDL, mmol/L 999 1.510.42 1.500.41 1.510.42 1.510.43 0.98
Glucose, mmol/L 1000 5.160.72 4.960.58 5.080.55 5.460.90 <0.001
PWV, m/s 923 7.902.22 7.141.37 7.531.82 9.082.76 <0.001
BMI indicates body mass index; BP, blood pressure; CKD, chronic kidney disease; CVD, cardiovascular disease; DBP, diastolic blood pressure; dp-ucMGP, dephospho-uncarboxylated matrix
Gla (c-carboxyglutamate) protein; GFR, glomerular ﬁltration rate; HDL, high-density lipoprotein; HR, heart rate; LDL, low-density lipoprotein; PP, pulse pressure; PWV, pulse wave velocity;
RRI, renal resistive index; SBP, systolic blood pressure.
*P=0.03 for trend.
†P=0.04 for trend.
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Association of dp-ucMGP With RRI
In univariable analyses, all independent variables except LDL,
HDL, and DBP were associated with RRI (Table 2). A positive
association of dp-ucMGP with RRI was noted (Figure 1): every
1-U increase in dp-ucMGP (nmol/L) increased RRI by 8.1%.
Multivariable analyses included 970 patients without miss-
ing data (Table 2). Factors associated with RRI were dp-ucMGP,
sex, age, age squared, BMI, HR, LDL, glucose, SBP, and DBP (all
P<0.05). In the ﬁnal model, every 1-U increase in dp-ucMGP
(nmol/L) was associated with an increase of 2.2% RRI. During
the backward stepwise procedure, variables were discarded in
the following order: eGFR, diabetes mellitus, smoking, and
history of CVD (Table S1). The following variables were
discarded from the outset and thus not considered in the
backward stepwise procedure, as they were not associated
with either RRI or dp-ucMGP in initial multivariable models (see
Methods): height, HDL, BP, and lipid-lowering drugs.
In multivariable logistic regression, dp-ucMGP was signif-
icantly associated with RRI >70% (coefﬁcient: 2.59; 95% CI,
1.11–4.08; P=0.001).
Sensitivity and Secondary Analyses
In sensitivity analyses, results were globally similar when
accounting for outliers (Table S2). Moreover, no interaction was
found between dp-ucMGP and abnormal kidney on ultrasound,
sex, chronic kidney disease, antihypertensive treatment, and
hypertension (interaction term, P>0.1; LRT, P>0.1 for all).
However, a signiﬁcant interaction was found between dp-
ucMGP and age in tertiles (P<0.001 for interaction term and
LRT). The strength and signiﬁcance of the association between
dp-ucMGP and RRI increased across tertiles of age (Figure 2).
In the multivariable analysis stratiﬁed by age category, there
was no signiﬁcant association in the youngest group (aged 18–
38 years: b=0.53; 95% CI, 2.62 to 1.56; P=0.62), whereas
the association was signiﬁcant in the older groups (aged 38–55
years: b=2.58; 95% CI, 0.47–4.48; P=0.016; aged ≥55 years:
b=4.62; 95% CI, 2.53–6.72; P<0.001).
In secondary analyses, PP and PWV showed a positive
relationship with RRI (Pearson correlation coefﬁcients of 0.59
and 0.45, respectively). However, graphical assessment
showed nonlinearity, speciﬁcally, at the lowest PP and PWV
Table 2. Factors Associated With RRI in Univariable and Multivariable Mixed Linear Regression Models (n=970 for All Models,
Without Outliers)
Independent Variable
Univariable Model Full Model Final Model
b 95% CI P Value b 95% CI P Value b 95% CI P Value
dp-ucMGP, nmol/L 8.06 6.60–9.53 <0.001 2.17 0.96–3.42 0.001 2.18 0.96–3.41 0.001
Sex (female) 1.63 1.03–2.22 <0.001 1.88 1.19–2.57 <0.001 1.73 1.27–2.18 <0.001
Smoker (yes) 1.08 1.80 to 0.37 0.003 0.29 0.21 to 0.79 0.26   
Diabetes mellitus (yes) 6.24 4.62–7.87 <0.001 0.64 0.71 to 1.98 0.35   
BP drugs (yes) 4.60 3.79–5.41 <0.001 0.19 0.49 to 0.87 0.59   
Lipid drugs (yes) 2.54 0.93–4.16 0.002 0.55 1.68 to 0.59 0.35   
CVD (yes) 3.95 2.96–4.93 <0.001 0.51 0.23 to 1.24 0.18   
Age, y 0.33 0.40 to 0.26 <0.001 0.15 0.23 to 0.07 <0.001 0.16 0.23 to 0.08 <0.001
Age2, y 0.01 0.004–0.006 <0.001 0.003 0.002–0.003 <0.001 0.003 0.002–0.004 <0.001
Body height, cm 0.17 0.20 to 0.14 <0.001 0.01 0.04 to 0.03 0.79   
BMI, kg/m2 0.19 0.12–0.26 <0.001 0.06 0.00–0.12 0.049 0.08 0.02–0.14 0.006
SBP, mm Hg 0.11 0.09–0.13 <0.001 0.12 0.10–0.15 <0.001 0.13 0.10–0.15 <0.001
DBP, mm Hg 0.02 0.06 to 0.01 0.15 0.22 0.25 to 0.18 <0.001 0.22 0.26 to 0.18 <0.001
HR, beats/min 0.06 0.09 to 0.03 <0.001 0.05 0.07 to 0.03 <0.001 0.05 0.07 to 0.03 <0.001
GFR, mL/min/1.73 m2 0.12 0.13 to 0.10 <0.001 0.001 0.02 to 0.02 0.95   
LDL, mmol/L 0.15 0.19 to 0.48 0.39 0.25 0.51 to 0.01 0.06 0.29 0.54 to 0.04 0.025
HDL, mmol/L 0.24 0.50 to 0.99 0.52 0.58 1.20 to 0.04 0.07   
Glucose, mmol/L 1.98 1.55–2.42 <0.001 0.58 0.19–0.99 0.07 0.66 0.30–1.02 <0.001
All models are adjusted for center as ﬁxed effect and for family as random effect. b corresponds to 1-U increase. BMI indicates body mass index; BP, blood pressure; CVD, cardiovascular
disease; DBP, diastolic blood pressure; dp-ucMGP, dephospho-uncarboxylated matrix Gla (c-carboxyglutamate) protein; GFR, glomerular ﬁltration rate; HDL, high density lipoprotein; HR,
heart rate; LDL, low density lipoprotein; RRI, renal resistive index; SBP, systolic blood pressure.
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values (Figure S2). Because nonlinearity was conﬁrmed by
LRT, PP and PWV were used as tertiles in linear regressions. In
a mixed unadjusted linear regression model, PP and PWV
were both positively associated with RRI (both P<0.001). PP
and PWV were still signiﬁcantly associated with RRI after
adjustment for sex, age, BMI, HR, LDL, and glucose (P<0.001
and P=0.040, respectively).
Discussion
In this study we observed a positive association between RRI
and dp-ucMGP in a large, multicentric, family-based popula-
tion. This association was independent of other variables
previously known to inﬂuence RRI (age, sex, BMI, HR, SBP,
and DBP) and renal function and cardiovascular risk factors
(diabetes mellitus, treated hypertension, and smoking).
MGP as a Determinant of RRI
Soon after being introduced in 1974 as a measure of
intrarenal vascular resistance, RRI was used as a potential
marker of kidney damage. Indeed, RRI theoretically depends
on the capillary wedge pressure, representing a combination
of interstitial and venous pressures.6 Any pathological
process affecting one of these compartments should increase
RRI. This was illustrated for the ﬁrst time in 1991 in kidney
biopsies, as tubulointerstitial disease was associated with
higher RRI than isolated glomerulopathies.23 A larger study
including 992 patients with simultaneous RRI assessment and
kidney biopsy also showed that tubulointerstitial injury
correlated strongly with elevated RRI.3 Consequently, in
patients with established kidney injury, an elevated RRI
reﬂects—at least in part—the intrarenal pathological process
itself. In contrast, RRI could also reﬂect systemic vascular
properties rather than intrarenal pathological processes. The
most convincing data supporting this hypothesis thus far
came from an elegant study of 321 renal transplant recipi-
ents.4 In that study, RRI correlated with recipient age and
central hemodynamic factors but not with histopathological
ﬁndings on protocol-speciﬁed kidney biopsies. However,
because that study took place in a speciﬁc population of
transplanted patients, its generalizability is limited. The use of
calcineurin inhibitors, known to inﬂuence the RRI, also
hampered deﬁnite conclusions. The clinical interpretation of
RRI is further complicated by the fact that RRI can also be
seen as a marker of target kidney damage and a prognostic
predictor of renal and cardiovascular outcome. Therefore, RRI
A B C
P=0.33 P=0.035 P<0.001
Figure 2. Scatterplots showing the univariable association between dp-ucMGP and RRI depending on tertiles of age (n=970, without outliers
and no missing covariates). A, Younger tertile (ﬁrst): b=1.1 (95% CI, 3.3 to +1.1). B, Middle tertile (second): b=2.4 (95% CI, 0.2–4.7). C, Older
tertile (third): b=7.6 (95% CI, 5.1–10.0). Univariable P value for interaction <0.001. Red line represents linear regression line. P values from the
regression are represented. dp-ucMGP indicates dephospho-uncarboxylated matrix Gla (c-carboxyglutamate) protein; RRI, renal resistive index.
50
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Figure 1. Scatterplot showing the association between dp-
ucMGP and RRI (n=1006, without outliers). Red line represents
linear regression. Pearson correlation coefﬁcient is represented
with the corresponding P value. dp-ucMGP indicates dephospho-
uncarboxylated matrix Gla (c-carboxyglutamate) protein; RRI,
renal resistive index.
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was associated with albuminuria and left ventricular hyper-
trophy in 211 untreated hypertensive patients.24 Moreover,
RRI was predictive of a composite end point of cardiovascular
and renal events in 426 hypertensive patients followed for a
mean of 3.1 years.5 Conversely, dp-ucMGP was previously
associated with various cardiovascular outcomes in several
populations: high dp-ucMGP levels were associated with
below-knee arterial calciﬁcation scores in patients with type 2
diabetes mellitus and an increased risk of CVD independent of
classical risk factors in older patients free of CVD at
baseline.25,26 Moreover, dp-ucMGP has already been associ-
ated with vascular calciﬁcation and arterial stiffness.19,20,27–29
Our study provides new data from the general population.
The robust positive association of RRI with dp-ucMGP
described in our study links RRI, for the ﬁrst time, to a direct
pathophysiological marker of vascular calciﬁcation. Our
ﬁndings support the view that RRI is a marker of systemic
atherosclerotic burden. This hypothesis is reinforced by the
fact that the association between RRI and dp-ucMGP was
independent of classical determinants of RRI (age, sex, BMI,
HR) and, more important, from SBP and DBP. This ﬁnding
further supports the idea that RRI reﬂects the global vascular
calciﬁcation burden itself and not only systemic hemodynamic
properties. Moreover, in our study, the association between
RRI and dp-ucMGP was not inﬂuenced by the presence of
established CVD, traditional cardiovascular risk factors (dia-
betes mellitus, hypertension, and smoking), renal function,
and the presence of abnormality on renal ultrasound. This
highlights the idea that, in a general adult population, RRI
reﬂects global vascular calciﬁcation status despite the
absence of renal and cardiovascular clinical manifestations.
Globally, our ﬁndings shed new light on the intricate role of
RRI as a prognostic marker of renal and cardiovascular
outcomes.
Finally, age seemed to play a complex role in the
relationship between dp-ucMGP and RRI. The effect and
signiﬁcance of dp-ucMGP on RRI increased with advancing
age. However, this result is not surprising because the range
of absolute dp-ucMGP values was low in younger people and
thus less likely to reﬂect signiﬁcant vascular hemodynamic
impairment. Moreover, arterial stiffness is also known to
increase with age.
Determinants of RRI
Mathematical derivations also support the hypothesis that RRI
depends on systemic vascular and hemodynamic factors.
O’Neill stated that the RRI equation can be rewritten in the
following fashion6: RRI ¼ 1 PdiaP0PsysP0
LAsys
LAdia, where Psys
indicates systolic pressure, Pdia indicates diastolic pressure,
P0 indicates renal capillary wedge pressure, LAsys indicates
systolic vessel lumen area, and LAdia indicates diastolic
vessel lumen area. In most physiological situations, P0
(interstitial plus venous pressure) is negligible and RRI
indirectly depends on 2 central hemodynamic parameters:
PP (represented here by the ratio of Pdia/Psys) and vascular
compliance (represented here by the ratio of LAsys/LAdia).
RRI thus varies directly with PP and inversely with vascular
compliance. This interpretation of RRI sheds light on its
dependency on extrarenal hemodynamic factors such as age,
HR, and Valsalva maneuver.30–32 Experimental data support
this theoretical view. First, RRIs of perfused rabbit kidneys
showed a strong linear correlation with PP.8 Second,
Hashimoto and Ito7 showed that RRI was dependent on
aortic PP measured by applanation tonometry and aortic
compliance measured by carotid–femoral PWV in 133 hyper-
tensive patients. However, when using multivariable analysis,
only aortic PP (not aortic compliance) was independently
associated with RRI, suggesting that PP was the main
physiological factor. Our ﬁndings globally agree with this
model. Even after accounting for a nonlinear relationship, PP
measured by manual auscultatory sphygmomanometer and
aortic compliance measured by carotid–femoral PWV both
showed a strong positive correlation with RRI. However, PWV
seemed to play a weaker role than PP; its univariable
correlation with RRI was smaller, and its statistical signiﬁ-
cance in multivariable analysis decreased substantially. This
result again supports the fact that PP is an independent
determinant of RRI, whereas aortic compliance could merely
represent a secondary effect on the causal process. Globally,
our ﬁndings conﬁrm that in a healthy adult population, RRI is
strongly dependent on extrarenal systemic hemodynamic
factors.
Limitations
The main limitation of our study is the observational and
cross-sectional nature of the association between RRI and dp-
ucMGP, which limits causal inference. Moreover, despite
adjusting for clinically relevant variables, including known
confounders, we cannot exclude potential residual confound-
ing. RRI measurements were performed in 3 different study
centers. However, the center effect was accounted for in
linear regressions, and interobservator reproducibility was
excellent. Strengths of our study include the large sample size
with >1000 participants and the population-based design,
which increases its generalizability. However, this study
included people of European descent, and whether similar
associations exist in non-European populations remains an
open question. RRI could be inﬂuenced by intra-abdominal
pressure, hematoma, or cirrhosis, but because mainly healthy
participants were included, we do not believe those conditions
would signiﬁcantly inﬂuence our results. Moreover, all
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measurements were performed in expiration, which reduces
the inﬂuence of intra-abdominal pressure. RRI also depends
on stroke volume, which was not measured in our study.
However, there is no physiological argument that adjustment
for this parameter would alter the strength or direction of the
association between RRI and dp-ucMGP.
Conclusions
The robust independent positive association between RRI and
dp-ucMGP suggests that RRI directly reﬂects the global
atherosclerotic burden in a general population of healthy
participants. This ﬁnding strengthens the potential role of RRI
as a subclinical and prognostic marker of cardiovascular
outcomes. Further prospective studies are needed to clarify
whether MGP and RRI can be used as a stratiﬁcation tool in
the evaluation of individual cardiovascular risk.
It has already been shown that vitamin K supplementation
dose-dependently decreases dp-ucMGP circulating levels and
improves elastic properties of arterial vessel walls.16,33,34 Our
ﬁndings suggest that an elevated RRI could identify patients
beneﬁting from such supplementation. Whether this supple-
mentation would result in a meaningful improvement in
clinical outcome remains to be demonstrated in randomized
controlled trials.
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 Table S1. Backward stepwise mixed linear regression (without outliers) for RRI on 970 patients. 
Independent variables Full model Step 1 Step 2 Step 3 Step 4 
 β p β p β p β p β p 
Dp-ucMGP (nmol/l) 2.22 0.001 2.23 <0.001 2.18 0.001 2.11 0.001 2.18 0.001 
Sex (female) 1.75 <0.001 1.76 <0.001 1.77 <0.001 1.73 <0.001 1.73 <0.001 
Smoker (yes) 0.35 0.17 0.35 0.17 0.34 0.18     
Diabetes (yes) 0.67 0.32 0.67 0.32       
CV disease (yes) 0.55 0.14 0.55 0.14 0.57 0.12 0.56 0.13   
Age (years) -0.16 <0.001 -0.16 <0.001 -0.16 <0.001 -0.16 <0.001 -0.16 <0.001 
Age2 (years2) 0.003 <0.001 0.003 <0.001 0.003 <0.001 0.003 <0.001 0.003 <0.001 
BMI (kg/m2) 0.08 0.009 0.08 0.009 0.08 0.007 0.08 0.009 0.08 0.006 
SBP (mmHg) 0.13 <0.001 0.13 <0.001 0.13 <0.001 0.13 <0.001 0.13 <0.001 
DBP (mmHg) -0.22 <0.001 -0.22 <0.001 -0.22 <0.001 -0.22 <0.001 -0.22 <0.001 
Heart rate (1/min) -0.05 <0.001 -0.05 <0.001 -0.05 <0.001 -0.05 <0.001 -0.05 <0.001 
GFR (ml/min/m2) -0.001 0.90         
LDL (mmol/l) -0.23 0.07 -0.23 0.07 -0.26 0.047 -0.26 0.041 -0.29 0.025 
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 Glucose (mmol/l) 0.58 0.005 0.58 0.005 0.66 <0.001 0.66 <0.001 0.66 <0.001 
 
All models adjusted for center as fixed effect. 
RRI, renal resistive index; BP, blood pressure; CV, cardiovascular; CKD, chronic kidney disease; BMI, body mass index; SBP, 
systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; dp-ucMGP, dephospho-uncarboxylated matrix Gla protein; 
GFR, glomerular filtration rate; LDL, low dendity lipoprotein; HDL, high density lipoprotein; PWV, pulse wave velocity. 
Definitions: Diabetes, reported or treated or fasting blood glucose level >7 mmol/l. 
All models are adjusted for center as fixed effect and family as random effect. β corresponds to 1 unit increase. 
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 Table S2. Factors associated with RRI in multivariate mixed linear regression 
models with outliers but no missing covariates (N=1’025). 
Independent 
variables 
Final model with extreme outliers 
 β 95% CI p 
Dp-ucMGP (nmol/l) 1.71 0.74; 2.67 0.001 
Sex (women) 1.71 1.26; 2.15 <0.001 
Age (years) -0.15 -0.23; -0.08 <0.001 
Age2 (years) 0.003 0.002; 0.004 <0.001 
BMI (kg/m2) 0.09 0.04; 0.15 0.001 
SBP (mmHg) 0.14 0.11; 0.16 <0.001 
DBP (mmHg) -0.24 -0.28; -0.20 <0.001 
HR (1/min) -0.06 -0.08; -0.03 <0.001 
LDL (mmol/l) -0.26 -0.50; -0.01 0.041 
Glucose (mmol/l) 0.71 0.36; 1.07 <0.001 
 
RRI, renal resistive index; BMI, body mass index; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; HR, heart rate; dp-ucMGP, dephospho-uncarboxylated 
matrix Gla protein; LDL, low density lipoprotein. 
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 Figure S1. Study flowchart. 
 
 
RRI, renal resistive index; dp-ucMGP, dephospho-uncarboxylated matrix Gla protein
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 Figure S2. Scatterplots showing the univariate association between RRI, PP and PWV.  
 
 
a. Renal Resistive Index and Pulse Pressure 
b. Renal Resistive Index and Pulse Wave Velocity 
Pearson correlation coefficients are represented in the graph with the corresponding p-value. 
RRI, renal resistive index; PP, pulse pressure; PWV, pulse wave velocity. 
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